© Drug Hunter Inc. 2018-2023
Home > “compound 34”
oral PARP1-selective polymerase inhibitor
oral efficacy in BRCA1 mutant xenograft
from scaffold hopping from lit. PARP1/2 inh.
Bioorg. Med. Chem., Oct. 6, 2020
Lupin Ltd., Pune, IN
“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year